NYSE:HQHTekla Healthcare Investors Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Tekla Healthcare Investors Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $21.28 +0.30 (+1.43 %) (As of 05/25/2020 11:18 AM ET) Add Compare Share Today's Range$20.87Now: $21.28▼$21.3350-Day Range$16.98MA: $19.81▼$21.2452-Week Range$13.78Now: $21.28▼$21.69Volume170,936 shsAverage Volume226,342 shsMarket Capitalization$901.00 millionP/E RatioN/ADividend Yield8.36%Beta1.25 ProfileAdvanced ChartCompetitorsDividendFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Tekla Healthcare Investors. Previous Next 2.4 Community Rank Outperform VotesTekla Healthcare Investors has received 123 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTekla Healthcare Investors has received 129 “underperform” votes. (Add your “underperform” vote.)Community SentimentTekla Healthcare Investors has received 51.19% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Tekla Healthcare Investors and other stocks. Vote “Outperform” if you believe HQH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HQH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipTekla Healthcare Investors is a leading dividend payer. It pays a dividend yield of 8.36%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthTekla Healthcare Investors does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Tekla Healthcare Investors insiders have bought more of their company's stock than they have sold. Specifically, they have bought $215,482.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 7.30% of the stock of Tekla Healthcare Investors is held by insiders.Percentage Held by InstitutionsOnly 20.99% of the stock of Tekla Healthcare Investors is held by institutions. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.41 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Investment offices, not elsewhere classified Sub-IndustryN/A SectorFinance Current SymbolNYSE:HQH Previous Symbol CUSIPN/A CIK805267 Webwww.teklacap.com Phone617-772-8500Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares42,340,000Market Cap$901.00 million Next Earnings DateN/A OptionableNot Optionable HQH Rates by TradingView Receive HQH News and Ratings via Email Sign-up to receive the latest news and ratings for HQH and its competitors with MarketBeat's FREE daily newsletter. Tekla Healthcare Investors (NYSE:HQH) Frequently Asked Questions How has Tekla Healthcare Investors' stock been impacted by COVID-19 (Coronavirus)? Tekla Healthcare Investors' stock was trading at $17.87 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HQH shares have increased by 19.1% and is now trading at $21.28. View which stocks have been most impacted by Coronavirus. How often does Tekla Healthcare Investors pay dividends? What is the dividend yield for Tekla Healthcare Investors? Tekla Healthcare Investors declared a quarterly dividend on Tuesday, May 19th. Investors of record on Friday, May 29th will be given a dividend of $0.41 per share on Tuesday, June 30th. This represents a $1.64 annualized dividend and a yield of 7.71%. The ex-dividend date is Thursday, May 28th. View Tekla Healthcare Investors' dividend history. Has Tekla Healthcare Investors been receiving favorable news coverage? Headlines about HQH stock have been trending somewhat positive on Monday, according to InfoTrie. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Tekla Healthcare Investors earned a daily sentiment score of 1.5 on InfoTrie's scale. They also gave press coverage about the financial services provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutTekla Healthcare Investors. Who are some of Tekla Healthcare Investors' key competitors? Some companies that are related to Tekla Healthcare Investors include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tri-Continental (TY), Hercules Capital (HTGC), Royce Value Trust (RVT), Gabelli Equity Trust (GAB), Liberty All-Star Equity Fund (USA), Tortoise Energy Infrastructure (TYG), Boulder Growth & Income Fund (BIF), Blackrock Muniyield Insured Fund (MYI), AllianceBernstein Global Hgh Incm Fd (AWF), Invesco Van Kampen Munpl Oprtnty Tr (VMO) and General American Investors (GAM). View all competitors. What other stocks do shareholders of Tekla Healthcare Investors own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Healthcare Investors investors own include AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Enterprise Products Partners (EPD), Ares Capital (ARCC), General Electric (GE), Macquarie Infrastructure (MIC), Omega Healthcare Investors (OHI), Hoegh LNG Partners (HMLP) and Pimco Dynamic Credit and MortggeIncmFund (PCI). Who are Tekla Healthcare Investors' key executives? Tekla Healthcare Investors' management team includes the following people: Dr. Daniel R. Omstead M.S, Ph.D., CEO, Pres & Trustee (Age 66)Ms. Kimberley L. Carroll, CFO, CFO - HQL Fund, VP & Treasurer of Hambrecht & Quist Capital Mgmt LLC (Age 63)Ms. Laura F. Woodward, Chief Compliance Officer, Treasurer and Sec. (Age 51)Dr. Jason C. Akus M.D., MBA, VP of Research and Portfolio Mang.Mr. Christopher F. Brinzey, Sr. VP of Research and Portfolio Mang. What is Tekla Healthcare Investors' stock symbol? Tekla Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQH." Who are Tekla Healthcare Investors' major shareholders? Tekla Healthcare Investors' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Morgan Stanley (7.10%), Karpus Management Inc. (1.15%), Needham Investment Management LLC (0.83%), Wells Fargo & Company MN (0.72%), Raymond James Financial Services Advisors Inc. (0.69%) and Advisors Asset Management Inc. (0.69%). View institutional ownership trends for Tekla Healthcare Investors. Which major investors are selling Tekla Healthcare Investors stock? HQH stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Raymond James & Associates, Doliver Advisors LP, Wolverine Asset Management LLC, AE Wealth Management LLC, City of London Investment Management Co. Ltd., Advisors Asset Management Inc., and Needham Investment Management LLC. View insider buying and selling activity for Tekla Healthcare Investors. Which major investors are buying Tekla Healthcare Investors stock? HQH stock was bought by a variety of institutional investors in the last quarter, including Karpus Management Inc., Advisor Group Holdings Inc., Matisse Capital, RMB Capital Management LLC, Strategic Wealth Advisors Group LLC, Private Advisor Group LLC, Eudaimonia Partners LLC, and Twin Focus Capital Partners LLC. View insider buying and selling activity for Tekla Healthcare Investors. How do I buy shares of Tekla Healthcare Investors? Shares of HQH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Tekla Healthcare Investors' stock price today? One share of HQH stock can currently be purchased for approximately $21.28. How big of a company is Tekla Healthcare Investors? Tekla Healthcare Investors has a market capitalization of $901.00 million. What is Tekla Healthcare Investors' official website? The official website for Tekla Healthcare Investors is www.teklacap.com. How can I contact Tekla Healthcare Investors? Tekla Healthcare Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The financial services provider can be reached via phone at 617-772-8500 or via email at [email protected] This page was last updated on 5/25/2020 by MarketBeat.com Staff
